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The CC chemokine ligand 2 (CCL2, monocyte chemoattractant protein-1) is important in coordinating the immune response following
microbial infection by regulating T cell polarization as well as leukocyte migration and accumulation within infected tissues. The present
study examines the consequences of mouse hepatitis virus (MHV) infection in mice lacking CCL2 (CCL2/) in order to determine if
signaling by this chemokine is relevant in host defense. Intracerebral infection of CCL2/ mice with MHV did not result in increased
morbidity or mortality as compared to either wild type or CCR2/ mice and CCL2/ mice cleared replicating virus from the brain. In
contrast, CCR2/ mice displayed an impaired ability to clear virus from the brain that was accompanied by a reduction in the numbers of
antigen-specific T cells as compared to both CCL2/ and wild-type mice. The paucity in T cell accumulation within the central nervous
system (CNS) of MHV-infected CCR2/ mice was not the result of either a deficiency in antigen-presenting cell (APC) accumulation within
draining cervical lymph nodes (CLN) or the generation of virus-specific T cells within this compartment. A similar reduction in macrophage
infiltration into the CNS was observed in both CCL2/ and CCR2/ mice when compared to wild-type mice, indicating that both CCL2
and CC chemokine receptor 2 (CCR2) contribute to macrophage migration and accumulation within the CNS following MHV infection.
Together, these data demonstrate that CCR2, but not CCL2, is important in host defense following viral infection of the CNS, and CCR2
ligand(s), other than CCL2, participates in generating a protective response.
D 2004 Elsevier Inc. All rights reserved.
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Chemokines are small (7–15 kDa) cytokines capable of
inducing a diverse array of biological effects that are
important in both host defense and disease progression in
response to infection. Although initially described in induc-0042-6822/$ - see front matter D 2004 Elsevier Inc. All rights reserved.
doi:10.1016/j.virol.2004.09.006
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1 These authors contributed equally to this work.ing the directional migration of targeted populations of
leukocytes during periods of inflammation, chemokines are
now recognized as important signaling molecules in linking
innate and adaptive immune responses (Baggiolini, 1998;
Cyster, 1999; Luster, 1998, 2002; Ward et al., 1998). For
example, the CC chemokine ligand 2 (CCL2) is capable of
regulating the pathobiology of various inflammatory disease
models of humans such as asthma, multiple sclerosis, and
atherosclerosis (Boring et al., 1998; Gosling et al., 1999; for
reviews, see Baggiolini, 2001; Gerard and Rollins, 2001; Gu
et al., 1999; Mahad and Ransohoff, 2003). In addition to its
potent chemoattractive effect on monocytes and macro-04) 251–260
K.S. Held et al. / Virology 329 (2004) 251–260252phages, CCL2 also influences Th2 polarization in response to
certain antigenic challenge (Gu et al., 2000; Hogaboam et al.,
1998; Karpus and Kennedy, 1997; Warmington et al., 1999).
The influence of CCL2 on T cell polarization may be due to
the fact that CCL2 is constitutively expressed within
secondary lymphoid tissue and would be capable of affecting
cellular responses following exposure to antigen (Gu et al.,
2000). Thus, expression of CCL2 is capable of influencing
both innate as well as adaptive immune responses by
regulating monocyte and T cell responses, respectively.
Mouse hepatitis virus (MHV) is a positive-strand RNA
virus that is a member of the Coronaviridae family of
viruses. Intracranial instillation of MHV into the CNS of
susceptible mice results in widespread replication of virus in
neurons and glia accompanied by a robust inflammatory
response consisting of neutrophils, NK cells, T cells, and
macrophages (Williamson and Stohlman, 1990). T cells are
required for reduction of viral burden within the brain and
this process is mediated by secretion of IFN-g and perforin-
mediated lysis of infected cells (Bergmann et al., 2001;
Parra et al., 1999, 2001; Pearce et al., 1994; Williamson and
Stohlman, 1990; Yamaguchi et al., 1991). Clearance is
incomplete and surviving mice will often develop an
immune-mediated demyelinating disease characterized by
viral persistence in white matter tracts accompanied by
lesions of white matter damage (Dales and Anderson, 1995;
Fazakerley and Buchmeier, 1993; Lane and Buchmeier,
1997). Instillation of MHV into the CNS of mice results in a
regulated expression of chemokine genes that is dictated, in
part, by viral burden (Lane et al., 1998). In addition, the
functional contributions of chemokines and their receptors
to either host defense or disease development are dependent
on the stage of disease, for example, acute or chronic (Chen
et al., 2001; Glass and Lane, 2003a, 2003b; Glass et al.,
2001; Lane et al., 1998, 2000; Liu et al., 2000, 2001; Trifilo
et al., 2003). Analysis of chemokine receptor expression
following MHV infection reveals that the CC chemokine
receptors 2 (CCR2) and 5 (CCR5) are expressed by
endogenous cells of the CNS as well as by inflammatory
T cells and macrophages, indicating a role for these
receptors in regulating both the immune response and
disease development (Chen et al., 2001; Glass and Lane,
2003a, 2003b; Glass et al., 2001). Indeed, MHV infection of
CCR2/ mice resulted in a dramatic increase in mortality
and enhanced viral recovery from the brain that correlated
with reduced T cell and macrophage entry into the CNS as
compared to viral infection of CCR2+/+ mice (Chen et al.,
2001). The attenuated inflammatory response within the
CNS observed in MHV-infected CCR2/ mice was
associated with a muted Th1 immune response characterized
by an impaired ability to generate antigen-specific T cells
(Chen et al., 2001). Therefore, these data clearly indicate
that CCR2 is important in defense against MHV infection of
the CNS by promoting a protective Th1 response.
The present study examines the consequences of MHV
infection in mice lacking the major CCR2 signaling ligandCCL2 (CCL2/) in order to determine if signaling by this
chemokine is relevant in the generation of an effective
immune response and host defense. This is an important
question as CCR2 is currently the only known functional
receptor for CCL2, yet these molecules appear to have
markedly different effects on immune response to antigenic
challenge. CCL2 is important in the development of Th2
responses whereas CCR2 promotes a Th1 response while
muting a Th2 response (Boring et al., 1997; Gu et al., 1997,
1999, 2000; Hogaboam et al., 1998; Traynor et al., 2000;
Warmington et al., 1999). The data presented indicate that
both CCL2 and CCR2 influence leukocyte migration into the
CNS in response to viral infection. However, CCR2 is clearly
more influential in directing Tcell trafficking into the CNS as
compared to CCL2, indicating that ligands other than CCL2
are important in signaling through the CCR2 receptor.Results
Intracranial infection of mice with MHV
Mice were infected intracranially with 10 PFU of MHV
and morbidity and mortality recorded. As shown in Fig. 1A,
clinical disease in CCR2/ mice was more severe
compared to both wild type and CCL2/ mice starting at
day 3 postinfection (pi), and this difference was significant
(P = 0.005) from days 4 to 7 pi. Moreover, MHV-infected
CCR2/ mice exhibited a more rapid onset of death
compared to the other experimental groups (Fig. 1B). In
contrast, the severity of disease in MHV-infected CCL2/
mice was reduced early following infection but eventually
no difference was detected as compared to wild-type mice.
Death was initially delayed in infected CCL2/ mice as
compared to wild-type mice; however, by day 9 pi, there
was no difference in mortality between these two groups of
mice (Fig. 1B). Examination of viral titers within the brains
of mice indicated that CCR2/ mice had significantly
higher titers as compared to wild-type mice at days 5 and 7
pi, and exhibited significantly higher viral titers within the
brains at later times pi when compared to both wild type and
CCL2/ mice (Table 1).
T cell and macrophage infiltration into the CNS of
MHV-infected mice
Both CD4+ and CD8+ T cells are required for optimal
clearance of virus from the brains of MHV-infected mice
(Bergmann et al., 2001; Lane et al., 2000; Pearce et al.,
1994; Williamson and Stohlman, 1990; Yamaguchi et al.,
1991). To assess the contributions of CCR2 and CCL2 to T
cell migration and accumulation within the CNS of MHV-
infected mice, brains were removed at defined times pi and
T cell infiltration determined by flow cytometry. The data
shown in Fig. 2 indicate that CD4+ and CD8+ T cell
infiltration into the CNS of infected CCL2/ and CCR2/
Table 1
Viral titers within brains of MHV-infected mice
Mouse Days
postinfection
Viral titer
log10 (PFU/g)
a
n
Wild type infected 5 5.7 F 0.09 8
7 5.5 F 0.08 22
10–12 3.0 F 0.52 10
CCL2/ infected 5 5.9 F 0.09 7
7 5.7 F 0.11 9
10–12 3.1 F 0.33 7
CCR2/ infected 5 6.0 F 0.03b 9
7 6.0 F 0.16c 9
10–12 4.5 F 0.18d 4
a All titer data are presented as mean F SEM. No virus was detected from
sham mice of all groups.
b P V 0.002 as compared to wild type at day 5 pi; not significant compared
to CCL2/ mice.
c P V 0.003 as compared to wild type at day 7 pi; not significant compared
to CCL2/ mice.
d P V 0.01 as compared to wild type at days 10–12 pi; P V 0.02 as
compared to CCL2/ at days 10–12 pi.
Fig. 1. Morbidity and mortality following MHV infection of the CNS. Wild
type, CCL2/, and CCR2/ mice (all on the C57BL/6 background) were
infected ic with 10 PFU of MHV and disease severity recorded. CCR2/
mice exhibited an overall increase in the severity of clinical disease
progression (A) as compared to wild type and CCL2/ mice, and this
correlated with a more rapid onset and overall increase in mortality (B).
Results presented were from five separate experiments. Wild-type mice, n =
54; CCR2/ mice, n = 28; CCL2/ mice, n = 29. Data were presented as
the mean F SEM. Clinical disease severity was significantly (*P V 0.005)
worse in CCR2/ mice when compared to wild type and CCL2/ mice.
K.S. Held et al. / Virology 329 (2004) 251–260 253is dramatically reduced as compared to wild-type mice.
However, comparison of T cell trafficking within the brains
of CCL2/ and CCR2/ reveals differences in the
functional contributions of each molecule to T cell migra-
tion. Examination of total numbers of T cells in the brains of
CCL2/ mice indicated that CD4+ T cell infiltration into
the CNS is reduced by 58% (P V 0.01) and 36% at days 5
and 7 pi, respectively, as compared to wild-type mice (Fig.
2A). CD8+ T cell trafficking into the CNS of CCL2/ mice
is reduced by 65% (P V 0.01) and 55% (P V 0.01) at days 5
and 7, respectively, as compared to wild-type mice (Fig.
2B). CD4+ and CD8+ T cell accumulation within the brainsof CCR2/ mice is also significantly reduced at days 5 and
7 in comparison to wild-type mice (Figs. 2A and B). A 75%
(P b 0.005) and 83% (P b 0.003) reduction in CD4+ T cells
present within the brain was observed in CCR2/ mice
when compared to wild-type mice at days 5 and 7 pi,
respectively (Fig. 2A). Similarly, CD8+ T cell recruitment
was impaired by 71% (P b 0.005) and 78% (P b 0.005) at
days 5 and 7 pi in comparison to T cell levels in wild-type
mice (Fig. 2B). Although total numbers of T cells were
reduced within the brains of CCL2/ mice at day 7
compared to wild-type mice, the overall percentage of CD4+
and CD8+ T cells present within the inflammatory infiltrate
was remarkably similar, indicating that the frequency of T
cells present within the cellular infiltrate examined was
comparable between wild type and CCL2/ mice (Figs. 2C
and D). Of the total cells isolated from the brains of wild-
type mice at day 7 pi, CD4+ and CD8+ T cells comprised 9%
and 11%, respectively, while CD4+ and CD8+ T cells
accounted for 10% and 9%, respectively, in the brains of
infected CCL2/ mice at this time (Figs. 2C and D). In
marked contrast, only between 0.5% and 3% of the
infiltrating cells into the CNS of CCR2/ mice at day 7
pi were CD4+ and CD8+ T cells (Figs. 2C and D).
In addition to examining T cell infiltration within the
CNS of MHV-infected mice, the ability of macrophages
(F480+CD45high) to migrate and accumulate in the brains of
mice was also determined. The data shown in Fig. 3 indicate
that macrophage trafficking into the brains of infected
CCL2/ and CCR2/ mice was reduced as compared to
wild-type mice. In contrast to T cell trafficking, there was a
similar reduction in the number of macrophages present
within the brains in both CCL2/ and CCR2/ mice,
indicating that both ligand and receptor are important in
directing these cells into the CNS in response to MHV
infection.
Fig. 2. Characterization of T cell infiltration into the CNS of MHV-infected mice. Wild type, CCL2/, and CCR2/ mice were infected ic with 10 PFU of
MHVand T cell infiltration into the CNS determined at days 5 and 7 pi. In order to determine the frequency and numbers of virus-specific T cells present within
the brains, mononuclear cells were surface stained for either CD4 or CD8 and IFN-g (intracellular) expression evaluated following stimulation with either the
defined CD4 epitope M133–147 or CD8 epitope S598–605. Total numbers of infiltrating CD4+ and CD8+ T cells are indicated in the left-hand y-axis while
numbers of antigen-specific CD4+ and CD8+ T cells are indicated in right-hand y-axis (A and B, respectively). Data are presented as the mean F SEM. The
frequency of infiltrating CD4+ and CD8+ T cells present within the brains of MHV-infected mice is indicated in the left-hand y-axis while the frequency of
antigen-specific CD4+ and CD8+ T cells is indicated in the right-hand y-axis (C and D, respectively). Data are presented as the average of frequencies. Results
presented were from two separate experiments; n = 7 for MHV-infected wild type and CCL2/ mice, n = 4 for MHV-infected CCR2/ mice. *P V 0.01 as
compared to infected wild type at the corresponding time point. **P V 0.005 to infected wild type at the corresponding time point and not significant as
compared to that of CCL2/ mice. ***P V 0.005 as compared to infected wild type at the corresponding time point and P V 0.05 as compared to infected
CCL2/ mice. aP V 0.05 as compared to antigen-specific CD4+ T cells from infected wild type at day 7 pi. Not significant as compared to that of CCL2/
mice. bP V 0.01 as compared to antigen-specific CD8+ T cells from infected wild type at day 7 pi. Not significant as compared to that of CCL2/
mice. cP V 0.001 as compared to antigen-specific CD4+ T cells from infected wild type at day 7 pi. Not significant as compared to that of CCL2/ mice. dP
V 0.04 as compared to antigen-specific CD8+ T cells from infected wild-type mice at day 7 pi. P V 0.05 as compared to antigen-specific CD8+ T cells from
infected CCL2/ mice at day 7 pi.
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MHV-infected mice
In order to determine the numbers and frequencies of
virus-specific T cells within the brains of infected mice, cells
were isolated at day 7 pi and viral specificity determined by
intracellular IFN-g staining following pulsing of cells with
defined T cell epitopes. Such analysis revealed a 10-fold
reduction (P V 0.05) in the number of CD4+ T cells
responding to the immunodominant epitope within the
transmembrane (M) protein at residues 133–147 (M133–
147) present within the brains of CCR2/ mice as
compared to wild-type mice (Fig. 2A) (Xue et al., 1995).In addition, the frequency of M133–147-specific CD4+ T
cells in CCR2/ mice (1.9%) was also reduced (P V
0.001) in comparison with wild-type mice (3.9%) (Fig. 2C).
In contrast, there was no dramatic difference in the overall
number or frequency of M133–147-specific CD4+ T cells in
the brains of CCL2/ mice (3.7%) when compared to wild-
type mice (Figs. 2A and C). The strain of MHV used for
these studies (V5A13.1) contains a deletion within the
surface (S) glycoprotein where the immunodominant CD8+
T cell epitope (S510–518) for MHV is located (Castro and
Perlman, 1995; Dalziel et al., 1986). Therefore, viral
specificity for CD8+ T cells was determined by looking at
cells responding to an additional CD8+ T cell epitope
Fig. 3. Macrophage infiltration into the CNS of MHV-infected mice. Wild
type, CCL2/, and CCR2/ mice were infected with 10 PFU of MHV
and macrophage infiltration determined. Total cells were isolated from the
brains of infected mice and sham (noninfected) mice at days 5 and 7 pi, and
F4/80+CD45high cells determined by flow cytometry using FITC-F4/80-
and PE-CD45-conjugated antibodies. Numbers presented indicate the total
number of dual-positive cells within the gated population. Data are
presented as the mean F SEM. Results presented were from two separate
experiments; n = 7 for MHV-infected wild type and CCL2/ mice, n = 4
for MHV-infected CCR2/ mice. *P V 0.004 as compared to infected
wild type at day 5 pi.
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(S598–605) (Castro and Perlman, 1995). Similar to the
CD4+ T cell results, there was an approximately 7-fold
reduction (P V 0.008) in numbers of CD8+ T cellsFig. 4. Expression of non-ELR CXC chemokine ligands 9 and 10. (A) Total RNA
subjected to RPA to assess transcript levels of CXCL9 and CXCL10. Sham (non
mouse at the indicated time pi. An L32 probe was included to verify consiste
autoradiography. Data are presented as normalized units representing the ratio of
probe set. Values were obtained from the scanned autoradiograph using NIH imaresponding to the S598–605 epitope in CCR2/ mice
and the frequency of these cells (5.1%) was also reduced
(P V 0.04) as compared to wild-type mice (10.4%) (Figs.
2B and D). Although numbers of S598–605-specific CD8+
T cells were reduced within the brains of CCL2/ mice,
this was not significant compared to wild type, and the
frequency (11.1%) was actually slightly higher (Figs. 2B
and D).
Expression of non-ELR CXC chemokine ligands
T cells are required for optimal host defense following
MHV infection of the CNS by reducing the viral burden.
The fact that CCR2/ mice exhibited significantly higher
viral titers within the brains and were not able to reduce the
viral load as compared to both MHV-infected CCL2/ and
wild-type mice suggested the possibility of impaired
expression of T cell chemoattractants. We have previously
demonstrated that the non-ELR CXC chemokine ligands 9
(CXCL9-Mig, monokine induced by interferon gamma) and
10 (CXCL10-IP-10, interferon inducible protein 10 kDa)
contribute in host defense against MHV infection by
recruiting T cells into the CNS following infection (Liu
et al., 2000, 2001). Examination of transcripts at days 5 and
7 pi revealed differential expression patterns for each
chemokine. At day 5 pi, low levels of CXCL9 transcripts
were detected in all mice examined with infected wild-type
mice exhibiting the lowest levels (Figs. 4A and B).
However, by day 7 pi, CXCL9 expression was elevated inwas isolated from the brains of MHV-infected mice at days 5 and 7 pi and
infected) mice were included as control. Each lane indicates an individual
ncy in RNA and assay performance. (B) Densitometric analysis of RPA
signal intensity of chemokine transcript to the internal L32 included in the
ge software. Data represent the mean F SEM.
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mice, indicating that the ability to generate substantial levels
of CXCL9 transcripts during acute disease was impaired in
these mice. Although CXCL10 transcript levels were
decreased in CCR2/ mice at day 5 pi when compared
to wild type and CCL2/ mice, equivalent levels were
observed in all mice by day 7 pi (Figs. 4A and B).
Comparison of antigen-presenting cells and antigen-specific
T cells within draining cervical lymph nodes
The results presented above suggest that CCR2 may
either be required for generation of antigen-specific T cells
or contributes to migration of antigen-specific T cells to the
brain. In order to address these possibilities, draining
cervical lymph nodes (CLNs) were removed from MHV-
infected wild type, CCL2/, and CCR2/ mice and the
frequency of antigen-presenting cell (APCs) (determined by
CD11c+ antigen expression) was assessed (Peters et al.,
2000, 2001; Traynor et al., 2002). Examination of CD11c+
cells present within the CLN at day 2 pi of all strains of mice
revealed no increase in the frequency of these cells as
compared to sham-infected mice (Fig. 5). By days 5 and 7
pi, all mice exhibited an increase in the percentage of
CD11c+ cells when compared to controls (Fig. 5). Both
CCR2/ and CCL2/ mice displayed an overall lower
frequency of CD11c+ cells within the CLN as compared to
wild-type mice at day 7 pi; however, these differences were
not significant. We next evaluated the frequency of virus-
specific T cells present in the CLN at day 5 pi in order to
determine if there were differences in the generation of anFig. 5. Characterization of inflammatory infiltrate in the CLN of MHV-
infected mice. Percent CD11c+ cells within the CLN was determined by
flow cytometry using a FITC-conjugated CD11c antibody. Data are
presented as the mean F SEM. Results presented were from four separate
experiments; 3–6 mice were used from each group at an experimental time
point.adaptive immune response. Intracellular staining for IFN-g
in response to exposure of T cells to defined CD4 and CD8
viral epitopes revealed CCR2/ mice had the highest
frequency of antigen-specific T cells remaining in the CLN
at this time, followed by CCL2/ mice, with wild-type
mice displaying the lowest frequency (Fig. 6). These data
clearly indicate that generation of MHV-specific T cells is
not impaired in mice lacking CCR2.Discussion
The data presented in this report clearly indicate that
both CCL2 and CCR2 enhance T cell and macrophage
trafficking into the CNS in response to MHV infection and
participate in a protective immune response. However,
there are dramatic differences in the level of contribution of
each molecule with regards to disease outcome. Virus-
specific T cells lacking CCR2 were unable to migrate into
the brains as efficiently when compared to T cells in wild
type or CCL2/ mice, and this correlated with increased
mortality (Fig. 1) and delayed clearance of virus from the
brains of CCR2/ mice (Table 1). These findings indicate
that CCR2 ligands other than CCL2 exhibit a greater
influence in coordinating a protective response as compared
to CCL2. In addition to CCL2, the CCR2 ligand CCL7
(monocyte chemoattractant protein-3, MCP-3) is also
expressed within the CNS of MHV-infected mice and
may influence T cell trafficking (Lane et al., 1998).
Importantly, the data presented support and extend an
earlier study by our group indicating that CCR2 signaling
contributed to host defense following MHV infection of the
CNS (Chen et al., 2001), and clearly demonstrate that the
major CCR2 ligand CCL2 is not necessary for viral
clearance from the brain. In addition, these data demon-
strate that lack of CCR2 signaling and disease outcome is
not dependent on the mouse strain as earlier studies were
performed in 129  B6 mice whereas the current study
utilized C57BL/6 mice (Chen et al., 2001).
The dramatic reduction in number and frequency of
antigen-specific T cells within the brains of MHV-infected
CCR2/ suggested that either the ability of T cells to
migrate in response to chemokine signals derived from
within the CNS was impaired or there was a dampened
ability to generate antigen-specific T cells. In order to
answer these questions, we examined chemokine expression
within the brains as well as APC accumulation in draining
CLN. We have previously demonstrated that the chemo-
kines CXCL10 and CCL5 exert potent chemotactic effects
on Th1 cells following MHV infection and targeted
neutralization of either of these chemokines through use
of antibodies or knockout mice results in increased viral
titers within the brain accompanied by increased mortality
(Dufour et al., 2002; Glass and Lane, 2003a, 2003b; Liu et
al., 2000). The data presented in this study clearly indicate
that CCR2 also exerts a protective effect, in part, by aiding
Fig. 6. Analysis of MHV-specific T cells within the CLN of MHV-infected
mice. CCR2/, CCL2/, and wild-type mice were infected ic with 10
PFU of MHVand CLN isolated at day 5 pi, and the T cell response to virus
was determined. Harvested cells from experimental mice were pooled (three
mice per group) and stained for either CD4 or CD8 (FITC conjugated), and
IFN-g (PE conjugated) expression evaluated following stimulation with the
CD4 epitope M133–147 or CD8 epitope S598–605. The percent of
responding T cells from MHV-infected mice is shown. Data are presented
as the mean F SEM and representative of three separate experiments.
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mRNA expression profile within the brains of infected
CCR2/ mice reveals muted expression of CXCL9 tran-
scripts at day 7 pi. This may reflect the fact that T cell
infiltration was reduced at this time, and given that IFN-g is
important in enhancing CXCL9 gene transcription, this
could explain why transcript levels are reduced (Mahalin-
gam et al., 2001). In contrast, expression of CXCL10 was
comparable between all three groups of mice at each time
point examined. This is not completely surprising in that
type I interferons, which are expressed within the brains of
MHV-infected mice, can induce expression of CXCL10
(Campbell et al., 1999; Memet et al., 1991). Based on these
data, it is unlikely that the diminished expression of CXCL9
within the brains of infected CCR2/ mice accounts for the
dramatic decrease in T cell accumulation. Rather, this
deficiency is more likely the result of some other defect
resulting from impaired CCR2 signaling. One possibility
revolves around muted expression of other T cell chemokine
receptors, such as CXCR3, on T cells lacking CCR2. We
have previously demonstrated that MHV infection of either
CCL3/ or CCR5/ mice results in altered expression of
chemokine receptors on antigen-specific T cells that results
in a pronounced inability of these cells to migrate to sites of
infection (Glass et al., 2003a; Trifilo et al., 2003).
Recent studies have demonstrated that distinct popula-
tions of dendritic cells exist within secondary lymphoid
tissue and are responsive to chemokine signaling (Aliberti et
al., 2000; Luster, 2001, 2002; McColl, 2002; Serbina et al.,
2003). Indeed, CCR2 is expressed on professional APC
including macrophages and dendritic cells, and is thought tocontribute to defense following microbial challenge by
enhancing recruitment as well as production of antimicrobial
products such as TNF-a and NO by these cells (Luster, 2002;
McColl, 2002; Serbina et al., 2003). In addition, the absence
of CCR2 signaling results in diminished trafficking and
accumulation of dendritic cells within secondary lymphoid
tissues following antigenic challenge (Peters et al., 2000,
2001; Sato et al., 2000). The demonstration of a pronounced
deficiency in the ability to attract sufficient numbers of
antigen-specific T cells to control MHV replication within
the brain following infection of CCR2/ mice is consistent
with earlier studies that suggest an important role for CCR2
in contributing to T cell activation in other models of
microbial infection (Peters et al., 2000, 2001; Traynor et al.,
2002). The present data, however, show that mice lacking
CCR2 or its major ligand CCL2 do not have deficiencies in
the generation of MHV-specific CD4+ or CD8+ T cells,
although CCR2/ mice have a dramatic handicap in
trafficking of these T cells from the periphery into the
CNS. Indeed, analysis of draining CLN obtained fromMHV-
infected mice reveals an actual increase in the frequency of
virus-specific CD4+ and CD8+ T cells in CCR2/ mice
when compared to both wild type and CCL2/ mice,
suggesting an impaired ability to exit this tissue. This is
consistent with an earlier study by our laboratory demon-
strating that MHV infection of mice lacking CCL3 resulted
in the retention of virus-specific cells in the CLN, and this
was the result of impaired expression of chemokine
receptors, including CXCR3 and CCR5 that greatly aids T
cells in their ability to migrate to the brain (Trifilo et al.,
2003). Moreover, we have shown that chemokine expression
is important in the generation of effector T cells by enhancing
dendritic cell migration and activation. Mice lacking CCL3
exhibited a pronounced decrease in dendritic cell trafficking
to draining CLN, and this was accompanied by diminished
expression of T cell activation factors CD40 and MHC class
II in response to MHV infection and this correlated with
altered T cell responses (Trifilo and Lane, 2004). A similar
scenario may exist in mice lacking CCR2 as dendritic cells
express this chemokine receptor. Lack of CCR2 expression
on this population of cells may result in diminished
activation accompanied by an impaired ability to impart
key signals to antigen-specific T cells that enable them to exit
secondary lymphoid tissue and traffic to sites of infection.
We are currently examining this possibility.
Our laboratory has systematically characterized the
contributions of select chemokines in regulating immune
cell activation, migration, and trafficking in response to
instillation of MHV into the CNS of susceptible mice. In
addition, we have demonstrated important roles for chemo-
kines in linking innate and adaptive immune responses to
MHV infection of the CNS (Trifilo and Lane, 2004; Trifilo
et al., 2003). These studies have clearly indicated important
and nonredundant roles for certain chemokines in these
diverse biologic processes. Importantly, the data presented
highlight the complexity of chemokine signaling with
K.S. Held et al. / Virology 329 (2004) 251–260258regards to downstream effects on the ability of antigen-
sensitized T cells to migrate to sites of infection. Identi-
fication of the CCR2 ligand(s) important in imparting
information to MHV-specific T cells that enable these cells
to traffic into the CNS will provide information with regards
to how chemokine and chemokine receptors coordinate
immune responses following viral infection of the CNS.Materials and methods
Mice
CCL2/ and CCR2/ mice on C57BL/6 background
were generated as described previously (Kuziel et al., 1997;
Lu et al., 1998). Control wild-type C57BL/6 mice were
purchased from the National Cancer Institute. All mice were
bred and housed under specific pathogen-free conditions in
enclosed filter-top cages.
Virus
Mouse hepatitis virus (MHV) stain V5A13.1 [containing
a 142 amino acid deletion in the surface (S) glycoprotein]
was used in all studies described (Dalziel et al., 1986). Age-
matched (6–8 weeks) mice were anesthetized by inhalation
of methoxyflurane (Pitman-Moor, Inc., Washington Cross-
ing, NJ), followed by intracerebral (ic) injection with 10
PFU of MHV-V5A13.1 suspended in 30 AL of sterile saline.
Control (sham) animals were injected with sterile saline
alone. Mice were sacrificed at scheduled time points, and
brains and draining CLNs were collected. One-half of each
brain was used for plaque assay on the DBT astrocytoma
cell line to determine viral burden and the remaining halves
used for other experimental procedures (Chen et al., 2001;
Hirano et al., 1978; Liu et al., 2000).
Clinical disease
Following infection with virus, mice were evaluated for
signs of clinical disease using a previously described scale
(Lane et al., 1999, 2000). Scoring was based as follows: 0,
no abnormality; 1, limp tail; 2, waddling gait and partial
hindlimb weakness; 3, complete hindlimb paralysis; 4,
death.
Mononuclear cell isolation and flow cytometry
Mononuclear cells were obtained from brains and CLN
as previously described (Chen et al., 2001; Trifilo et al.,
2003). Fluorescein isothiocyanate (FITC)-conjugated rat
anti-mouse CD4 and CD8 antibodies were used to detect
CD4+ and CD8+ T cells (GK1.5 and Ly-2, respectively; BD
PharMingen, San Diego, CA). FITC-conjugated rat anti-
mouse F4/80 (C1:A3-1, Serotec, Oxford, UK) was used to
detect activated macrophage/microglial cells (Lane et al.,2000). Dual staining with FITC-F4/80 and R-Phycoerythrin
(PE)-CD45 (30-F11; BD PharMingen) was used to distin-
guish infiltrating macrophages from residential microglia
(Ford et al., 1995; Sedgwick et al., 1998). FITC-CD11c
(HL3; BD PharMingen) was used to stain dendritic cells
(Peters et al., 2000). In all cases, appropriate isotype-
matched FITC/PE antibodies were used as controls. Cells
were incubated with antibodies for 1 h at 4 8C, washed, and
fixed in 1% paraformaldehyde (Lane et al., 2000). Data
were acquired on a FACStar (Becton Dickinson, Mountain
View, CA) and analyzed by FlowJo software (Tree Star Inc.,
San Carlos, CA). Data are presented as the percent positive
within the gated population and then numerated based on
the number of total live cells per tissue.
Intracellular cytokine staining
Intracellular cytokine staining was performed using a
previously described procedure (Chen et al., 2001; Wu et
al., 2000). In brief, cells were collected from the brains or
CLN at scheduled time points and 1  106 total cells were
stimulated with viral peptides (Castro and Perlman, 1995;
Xue et al., 1995). After incubation for 6 h at 37 8C in media
containing Golgi stop (Cytofix/Cytoperm kit, BD PharMin-
gen), cells were washed and blocked with PBS containing
10% FBS and a 1:200 dilution of CD16/32 (BD PharMin-
gen). Cells were then stained for surface antigens with either
FITC-conjugated CD4, CD8, or Rat-IgG-2b (as control) for
1 h at 4 8C. Cells were fixed and permeabilized using
Cytofix/Cytoperm kit (BD PharMingen) and stained for
intracellular IFN-g using Phycoerythrin (PE)-conjugated
anti-IFN-g (1:50; XMG1.2, BD PharMingen) for 1 h at 4
8C. Data were acquired on a FACStar and analyzed by
FlowJo software. Data are presented as the percentage of
positive cells within the gated population. The absolute
numbers of antigen-specific CD4+ or CD8+ T lymphocytes
were calculated by multiplying the fraction of dual-positive
cells by the total number of cells obtained from the tissue.
Percentage of CD4/CD8 T cells that are virus specific was
calculated by dividing the dual-positive population by the
CD4/CD8-positive population.
Ribonuclease protection assay (RPA)
To detect chemokine mRNA transcripts within the CNS
of MHV-infected mice, total RNA was isolated from brains
at defined times pi using TRIZOL reagent (Invitrogen,
Carlsbad, CA) and subjected to an RNase protection assay
using previously described probes specific for mouse
CXCL9 and CXCL10 (Liu et al., 2001). L32 was included
in the probe set as an internal control to verify consistency
in RNA loading and assay performance. For quantification
of signal intensity, the autoradiograph was scanned and
individual chemokine bands were normalized as the ratio of
band intensity to the internal L32 control. Analysis was
performed with NIH Image 1.61 software.
K.S. Held et al. / Virology 329 (2004) 251–260 259Statistical analysis
Statistically significant differences between groups of
mice were determined by the Mann–Whitney rank sum test
and P values of b0.05 were considered significant.Acknowledgments
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